• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

NY Times: Fixation on Steve Jobs’ illness ‘unhealthy’

By
Philip Elmer-DeWitt
Philip Elmer-DeWitt
Down Arrow Button Icon
By
Philip Elmer-DeWitt
Philip Elmer-DeWitt
Down Arrow Button Icon
July 6, 2009, 8:39 AM ET
Steve Jobs in June, 2008

“Next February,” writes David Carr in Monday’s
New York Times
, “when Steven P. Jobs — knock on wood — does his big reveal at Macworld, the geegaw people will most want to see probably won’t be on display.”

So begins a piece by one of my favorite business columnists on a subject dear to my heart — Wall Street’s and the tech world’s obsession with the health of Apple’s (AAPL) CEO and, in particular, the “geegaws” of this story: Steve Jobs’ troubled pancreas and borrowed liver.

Carr is a smart and plugged-in observer of digital media, and once he gets over the glaring problem with his first sentence — Apple has already announced that it won’t be doing any more Macworlds, with or without Steve Jobs — he offers a useful perspective on what he calls our “unhealthy fixation” with Jobs’ illness: that of a fellow cancer survivor.

From that perspective — one shared by 10 million Americans, according to Carr — the “keening on the blogs, in the news media and in the investment community” for full disclosure from Apple about the state of Jobs’ health after his 2004 surgery for pancreatic cancer and more recent liver transplant, looks less like a legitimate financial concern and more like “the prurience … that drives most people’s interest in the illness of others,” especially celebrities.

“The same sense of entitlement that leads many to think that it is right and proper to suck the marrow from Michael Jackson’s bones pertains to the living, as well,” writes Carr. “There is an expectation that if you are both famous and sick, you will open up a vein and let the blood flow toward everyone. Farrah Fawcett invited everyone into her sickroom as she died of anal cancer and received the faux adoration of millions in return.”

That most of the sources Carr interviewed for his column — especially fellow Timesman Joe Nocera — felt there were legitimate reasons for asking whether Steve Jobs would be returning as scheduled from his medical leave, didn’t seem to faze the columnist. Carr kept calling until he reached someone who agreed with his thesis. “Everybody knows that Steve has a grave illness,” the futurist Paul Saffo helpfully volunteered. “This is sleazy entertainment, a sideshow.”

But sideshows, as Carr points out, are what the modern media do best. And Steve Jobs is a celebrity, he writes, with a particularly high-touch relationship with consumers:

“He sits at their fingertips, in their ears, connects them with friends … [And] because he seems to know us so well, or at least our needs, we like to think we know him back, even though nothing could be further from the truth. He is as inscrutable as Buddha and reportedly no barrel of monkeys to be around.”

Besides, Carr concludes, “Steve Jobs doesn’t want your love. He wants you to buy his stuff.”

See also:

  • Steve Jobs won’t give Macworld keynote
  • Apple: ‘Steve Jobs is back to work’
  • Inside Steve Jobs’ liver transplant
  • Steve Jobs’ liver transplant: The second-day stories

Photo: Getty Images

About the Author
By Philip Elmer-DeWitt
See full bioRight Arrow Button Icon

Latest in

CryptoBinance
Binance has been proudly nomadic for years. A new announcement suggests it’s finally chosen a headquarters
By Ben WeissDecember 7, 2025
5 hours ago
Big TechStreaming
Trump warns Netflix-Warner deal may pose antitrust ‘problem’
By Hadriana Lowenkron, Se Young Lee and BloombergDecember 7, 2025
8 hours ago
Big TechOpenAI
OpenAI goes from stock market savior to burden as AI risks mount
By Ryan Vlastelica and BloombergDecember 7, 2025
9 hours ago
InvestingStock
What bubble? Asset managers in risk-on mode stick with stocks
By Julien Ponthus, Natalia Kniazhevich, Abhishek Vishnoi and BloombergDecember 7, 2025
9 hours ago
EconomyTariffs and trade
Macron warns EU may hit China with tariffs over trade surplus
By James Regan and BloombergDecember 7, 2025
9 hours ago
EconomyTariffs and trade
U.S. trade chief says China has complied with terms of trade deals
By Hadriana Lowenkron and BloombergDecember 7, 2025
9 hours ago

Most Popular

placeholder alt text
Real Estate
The 'Great Housing Reset' is coming: Income growth will outpace home-price growth in 2026, Redfin forecasts
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
AI
Nvidia CEO says data centers take about 3 years to construct in the U.S., while in China 'they can build a hospital in a weekend'
By Nino PaoliDecember 6, 2025
2 days ago
placeholder alt text
Economy
The most likely solution to the U.S. debt crisis is severe austerity triggered by a fiscal calamity, former White House economic adviser says
By Jason MaDecember 6, 2025
1 day ago
placeholder alt text
Economy
JPMorgan CEO Jamie Dimon says Europe has a 'real problem’
By Katherine Chiglinsky and BloombergDecember 6, 2025
1 day ago
placeholder alt text
Big Tech
Mark Zuckerberg rebranded Facebook for the metaverse. Four years and $70 billion in losses later, he’s moving on
By Eva RoytburgDecember 5, 2025
3 days ago
placeholder alt text
Politics
Supreme Court to reconsider a 90-year-old unanimous ruling that limits presidential power on removing heads of independent agencies
By Mark Sherman and The Associated PressDecember 7, 2025
17 hours ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.